News Releases
News Releases
-
Sep 12, 2018
Sensus Healthcare, Inc. (Nasdaq: SRTS) announced today that it commenced a public offering of its common stock, par value $0.01 per share. B. Riley FBR is serving as the lead underwriter and sole...
-
Sep 7, 2018
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today...
-
Aug 27, 2018
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), today...
-
Aug 2, 2018Ships 21 systems including 12 SRT-100 Vision™ systems
Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT),...
-
Aug 2, 2018SRT-100+ Offers Advanced Features for Patients and Doctors, Including Remote Diagnostics and Patient Medical Records Integration, as Well as Core System Enhancements
Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radiation...